Nonmyeloablative Hematopoietic Cell Transplantation: Status Quo and Future Perspectives
Marco Mielcarek(Fred Hutch Cancer Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Stephen J. Forman(City Of Hope National Medical Center), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Karl G. Blume(City Of Hope National Medical Center), Michael B. Maris(Colorado Blood Cancer Institute), Beverly Torok‐Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lyle Feinstein(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David G. Maloney(Fred Hutch Cancer Center)
Cited by 31
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k